ClinicalTrials.gov
public full text
Public Domain
Effect of Vivomixx® on Neuroinflammation in Patients Withs Cirrhosis
Study Design: Double-blind randomized placebo-controlled clinical trial Study Duration: 2 years Study Center: Single center Hospital de la Santa Creu i Sant Pau, Barcelona Objectives: To assess the effect of Vivomixx® on neuroinflammation and systemic inflammatory response in patients with cirrhosis
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Clinical and Laboratory Factors Associated With In-Hospital Mortality Among Patients With Decompensated Liver Cirrhosis: A Retrospective Study From Indonesia.#354715
- Single Pass Albumin Dialysis in Patients With Cirrhosis#849666
- A Study of Glyceryl Tri-(4-phenylbutyrate) Administered Orally as a Single Dose, and Twice Daily for Seven Consecutive Days to Subjects With Hepatic Impairment With Cirrhosis and to a Control Group#1007195
- Clinical Classification of MAFLD Based Liver Biopsy#290888
- Study Of Bacterial/Fungal Infections in Hospitalized Patients With Liver Cirrhosis in China#249622
Record · ID 852439
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive